Real-world experience with elective discontinuation of PD-1 inhibitors at 1 year in patients with metastatic melanoma

by Siwen Hu-Lieskovan, Rebecca Pokorny, Jordan P McPherson, Carolyn Luckett, Benjamin Newell Voorhies, Daniel S Sageser, Jocelyn Wallentine, Zachary Tolman, Umang Swami
Published 2021-01-01